Leiomyomatosis - 25 Studies Found
| Completed |
: The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1) : Pulmonary Lymphangioleiomyomatosis : 2014-04-15 : Drug: Saracatinib Saracatinib is escalated as follows: Three dose levels will be administered for 1 mont |
| Completed |
: Trial of Aromatase Inhibition in Lymphangioleiomyomatosis : Lymphangioleiomyomatosis : 2011-05-11 :
|
| Completed |
: A Study to Determine the Effectiveness of Escalating Doses of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis : Lymphangioleiomyomatosis : 2010-01-28 : Drug: Everolimus |
| Recruiting |
: A Study of Nintedanib for LymphAngioleioMyomatosis (LAM) : Lymphangioleiomyomatosis : 2016-10-07 : Drug: Nintedanib Other Name: OFEV |
| Recruiting |
: Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis : Lymphangioleiomyomatosis : 2013-02-23 :
|
| Recruiting |
: Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis : Pulmonary Lymphangioleiomyomatosis : 2016-03-31 : Drug: saracatinib Subjects will receive enough tablets for 90 days +/- 14 days at each visit. Subject wi |
| Completed |
: Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis : Lymphangioleiomyomatosis : 2012-08-02 : Drug: sirolimus and hydroxychloroquine This will be a phase I dose escalation study of the combination o |
| Completed |
: Pulmonary Hypertension in Lymphangioleiomyomatosis :
: 2009-08-17 |
| Completed |
: Doxycycline In Lymphangioleiomyomatosis (LAM) :
: 2009-10-02 :
|
| Recruiting |
: Safety and Durability of Sirolimus for Treatment of LAM : Lymphangioleiomyomatosis : 2015-03-04 :
|